Delivery Order SPE2DB22D3501-SPE2DB25FWK93
Award Date 7/15/25
Potential Completion Date 8/5/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract valued at $19,341.02. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used primarily for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $37,133.84. This non-set-aside delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's corporate office in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, indicating this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $30,714.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Mekinist 0.5 mg tablets, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract was issued on July 10, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy used in the treatment of melanoma and other malignancies, representing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $9,670.51 and is scheduled for completion by August 26, 2025. The contract is not subject to any small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units), with an ultimate completion date of October 16, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $8.55K delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the breadth of pharmaceutical products procured...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...